Abstract
A retrospective chart analysis of 66 human immunodeficiency virus type 1 (HIV-1)-infected patients whose treatment was switched from stavudine to tenofovir without any other treatment changes was conducted. The mean total cholesterol values decreased significantly within 3 months after the tenofovir substitution and remained significantly less than baseline values during 18 months of follow-up (mean decrease, 36 mg/dL; P = .002). Regimens containing tenofovir provided effective control of HIV-1 infection, with stable CD4 + cell counts and continued suppression of plasma HIV-1 level following the treatment switch from stavudine.
Original language | English |
---|---|
Pages (from-to) | 145-147 |
Number of pages | 3 |
Journal | Clinical Infectious Diseases |
Volume | 42 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 1 2006 |
ASJC Scopus subject areas
- Immunology